Recombinant Adenosine Deaminase Ameliorates Inflammation, Vascular Disease, and Fibrosis in Preclinical Models of Systemic Sclerosis-Reference-Cited by-同舟云学术

Recombinant Adenosine Deaminase Ameliorates Inflammation, Vascular Disease, and Fibrosis in Preclinical Models of Systemic Sclerosis

Published:2020-06-25 Issue:8 Volume:72 Page:1385-1395
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Zhang Yun¹,Zhu Honglin²^ORCID,Layritz Florian¹,Luo Hui³,Wohlfahrt Thomas¹,Chen Chih‐Wei¹,Soare Alina¹^ORCID,Bergmann Christina¹,Ramming Andreas¹,Groeber Florian⁴,Reuter Christian⁴,Fornasini GianFranco⁵,Soukhareva Nadejda⁵,Schreiber Brian⁵,Ramamurthy Santosh⁵,Amann Kerstin⁶,Schett Georg¹^ORCID,Distler Jörg H. W.¹^ORCID

Affiliation:

1. University of Erlangen‐Nuremberg Erlangen Germany

2. University of Erlangen‐Nuremberg, Erlangen, Germany, and Xiangya Hospital and Central South University Changsha China

3. Xiangya Hospital and Central South University Changsha China

4. Universitätsklinikum Würzburg and Fraunhofer Institute for Interfacial Engineering and Biotechnology Würzburg Germany

5. Leadiant Biosciences, Inc. Gaithersburg Maryland

6. University Hospital Erlangen Erlangen Germany

Funder

Wilhelm Sander-Stiftung

Deutsche Forschungsgemeinschaft

Publisher

Wiley